Ref ID: 18585
Author:
M. Popova, N. Zubarovskaya, V. Vavilov, A. Volkova,
M. Averjanova, N. Klimko, B. Afanasyev
Author address:
I.P. Pavlov State Medical University (St. Petersburg, RU)
Full conference title:
Annual Meeting of the EBMT, 36th
Abstract:
Background: Invasive fungal infection (IFI) is a common cause
of morbility and mortality in patients undergoing HSCT. Only
25% IFI diagnosed while alive.
The aim. To compare incidence, risk factors of IFI in adults and
children after allogenic (allo), haploidentical (haplo) HSCT.
Patients: 236 patients (pts) were enrolled between 2000 and
2009. The adult group was 106 pts, age 21-68 (median 33 y.o.),
the children group 130 pts, age 1-21 (median 14 y.o.) suffered from acute leukemias – 167, myelo- and lymphoproliferative disorders – 31, lymphomas – 18, inherent disorders – 8,
others – 12. At the moment of HSCT in remission were 144,
in relapse – 92. The most pts were received allo-HSCT as
salvage therapy. Type of the donor: MRD – 130, MURD – 97,
haploidentical donor – 9. MAC used in 85, RIC in 151. Sources
of HSC: PBSC-154, BM-71, BM + PBSC-11. Median CD34 +
– 3-8 x 10
6
/kg. Acute GvHD prophylaxis was CsA + short course
of MTX or tacrolimus + MMF, plus ALG-60 mg/kg for MUD and
haplo-HSCT.
Results: The incidence of IFI following allo-HSCT was 32%. Possible IFI was detected in 30 (40%), probable IFI in 40 (53,4%)
and proven IFI in 5 (6,6%) according to the international defi nition criteria EORTC/MSG 2008. Median date of IFI onset was
D + 68 (1-940). The main causes of IFI were Aspergillus spp.
94%, Candida spp. 3%, Cryptococcus spp. 4%. The following risk factors were detected: in adults – usage of RIC, ATG,
development of mucositis (P < 0,05); in children - age older 10
years, mucositis IV, extensive chGvHD (P < 0,05).
The multivariate analyses revealed the synergistic effect of the
following risk factors: in children - combination of MUD, MAC,
and CMV-reactivation; MUD, RIC, relapse and BM as a source
of HSCT. In adults - MUD, RIC and CMV-reactivation; MUD,
RIC, remission and PBSC (P < 0,05). There were no cases of
IFI in pts with inherent disease. Overall survival (OS) in pts
undergoing HSCT with IFI versus without IFI was 18% vs. 55%
(children) and 30% vs. 30% (adult). Twelve-weeks OS children
vs. adult was 60% vs. 45%.
Conclusions: We revealed difference of risk factors of IFI in
children and adult and in OS in pts with IFI. The main risk factors for children are age older 10 years, mucositis IV, extensive chGvHD, for adults - usage of RIC, ATG, development of
mucositis.
Abstract Number: P769
Conference Year: 2010
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a